Cargando…
Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System
OBJECTIVES: Paclitaxel is a highly effective antitumor agent with notable adverse events, including hypersensitivity reactions, peripheral neuropathy, arthralgia, myalgias, and neutropenia. Solvent-based paclitaxel causes severe allergic, hypersensitivity, and anaphylactic reactions. Nanoparticle al...
Autores principales: | Naganuma, Misa, Tahara, Kohei, Hasegawa, Shiori, Fukuda, Akiho, Sasaoka, Sayaka, Hatahira, Haruna, Motooka, Yumi, Nakao, Satoshi, Mukai, Ririka, Hirade, Kouseki, Yoshimura, Tomoaki, Kato, Takeshi, Takeuchi, Hirofumi, Nakamura, Mitsuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413422/ https://www.ncbi.nlm.nih.gov/pubmed/30886713 http://dx.doi.org/10.1177/2050312119836011 |
Ejemplares similares
-
Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database
por: Hatahira, Haruna, et al.
Publicado: (2018) -
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database
por: Hasegawa, Shiori, et al.
Publicado: (2017) -
Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database
por: Naganuma, Misa, et al.
Publicado: (2018) -
Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system
por: Fukuda, Akiho, et al.
Publicado: (2017) -
Adverse events of smoking cessation treatments (nicotine replacement therapy and non-nicotine prescription medication) and electronic cigarettes in the Food and Drug Administration Adverse Event Reporting System, 2004−2016
por: Motooka, Yumi, et al.
Publicado: (2018)